OCREVUS (OCRELIZUMAB) — FDA Approval BLA761053 (GENENTECH INC)
OCREVUS (OCRELIZUMAB) — FDA Approval BLA761053 (GENENTECH INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OCREVUS; Active ingredients: OCRELIZUMAB; Application number: BLA761053.
| Brand name | OCREVUS |
|---|---|
| Active ingredients | OCRELIZUMAB |
| Application number | BLA761053 |
| Sponsor | GENENTECH INC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20170328 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →